Filing
Spy
Filing
Spy
Home
About
MRK
Merck & Co., Inc.
Global research-intensive biopharmaceutical company
CUSIP: 589331107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2019 Q2
11 of 35 quarters
Total Value
$89.48B
Total Shares
10.67M
Net Share Change
+9.84M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Kahn Brothers Group
$89.48B
10.67M
11.2%
ADD
+9.84M
(+1183.5%)
Kahn Brothers Group
$89.48B
10.67M shares
ADD
+9.84M
(+1183.5%)
MRK — Merck & Co., Inc. - FilingSpy